SciELO - Scientific Electronic Library Online

 
vol.21 issue4Assessment of a molecular biology test for identification of Mycobacterium tuberculosis and first and second line anti tuberculosis drug susceptibility in a tertiary referral hospital author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Infectio

Print version ISSN 0123-9392

Infect. vol.21 no.4 Bogotá Oct./Dec. 2017

 

EDITORIAL

Evidence based guidelines for congenital Chagas

Guias basadas en evidencia para Chagas congénito

Jorge E. Gomez-Marín* 

Editor in Chief Infectio

1* Editor in Chief Infectio Grupo GEPAMOL. Universidad Del Quindio, Colombia

In this issue ofInfectiowe present the version in English language of the Colombian guidelines for congenital Chagas. This guideline was published in Spanish inInfectioin April 20141. This guideline was a consensus report developed by the Colombian task force, that was integrated by experts in the field and financed by the Ministry of Health, Colciencias (Red Chagas Program Cont. Colciencias 080-2011) and the Pan American Health Organization.

Although of the success reducing vector borne transmission, congenitalTrypanosoma cruzitransmission is now estimated to account for 22% of new infections2, representing a significant international emergent public health problem. Currently, due to migration flux of Latin Americans to Europe, it is estimated that 68.000-120.000 people with Chagas disease are currently living in Europe3. However, up to 90% of Chagas disease cases in Europe remain undiagnosed. If no screening program is not established in this population of migrants, the congenital cases will be missed as the differential diagnosis is large and asymptomatic cases at birth (but with late serious consequences) are frequent4.

The Colombian Association of Infectious Diseases (ACIN) under- took the duty to do accessible for the non-Spanish speaking colleagues, the clinical guidelines for congenital Chagas. The Colombian experience can be very useful and we hope that will contribute to improve the diagnosis and treatment of children of Latin American parents that born in non-endemic countries.

Referencias

1. Cucunubá ZM, Valencia-Hernández CA, Puerta CJ, et al. Primer consenso colombiano sobre Chagas congénito y orientación clínica a mujeres en edad fértil con diagnóstico de Chagas.Infectio. 2014;18(2):50-65. doi:10.1016/j.infect.2013.12.001. [ Links ]

2. Messenger LA, Gilman RH, Verastegui M, et al. Towards improving early diagnosis of congenital Chagas disease in an endemic setting.Clin Infect Dis. 2017. doi:10.1093/cid/cix277. [ Links ]

3. Monge-Maillo B, López-Vélez R. Challenges in the management of Chagas disease in Latin-American migrants in Europe.Clin Microbiol Infect. 2017. doi:10.1016/j.cmi.2017.04.013. [ Links ]

4. Francisco-González L, Gastañaga-Holguera T, Jiménez Montero B, et al. [Seroprevalence and vertical transmission of Chagas disease in a cohort of Latin-American pregnant women in a tertiary hospital in Madrid].An Pediatr (Barc). 2017. doi:10.1016/j.anpedi.2017.03.003. [ Links ]

1Cómo citar este artículo: Jorge E. Gomez-Marín. Evidence based guidelines for congenital Chagas Infectio 2017; 21(4):201

Received: May 01, 2017; Accepted: May 03, 2017

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License